Register
|
Login
The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
NEWS
CONFERENCES
VIDEOS
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Precision Medicine
PUBLICATIONS
Evolving Paradigms
Targeted Therapies in Oncology
The Journal of Targeted Therapies in Cancer
ONCAlert | Upfront Therapy for mRCC
Case Studies
Case Studies: Prostate Cancer
Expert physicians provide insight on managing oncology-based patient cases that highlight the use of novel agents in clinical practice.
SORT BY:
A-Z
Recent
VIEW AS:
Grid
List
Hormone Sensitive Metastatic Castration-Resistant Prostate Cancer
Treatment Recommendations Upon Metastasis in CRPC
Therapeutic Approach for Nonmetastatic Prostate Cancer
Therapeutic Management of Nonmetastatic Prostate Cancer
Optimal Use of Bone-Targeted Therapy for mCRPC
mCRPC Treated with Concomitant ADT and Radium-223 Therapy
Metastatic Prostate Cancer with Charles Ryan, MD and William K. Oh, MD
Metastatic Prostate Cancer
Metastatic Castration-Resistant Prostate Cancer Issue 2
Metastatic Castration-Resistant Prostate Cancer
JTT Articles
The Role of Liquid Biopsy in NSCLC Continues to Emerge
Rare Incidence of ICI-Related Hepatotoxicity Frequently Ends in Treatment Discontinuation
Researchers Look to CAR T-Cell Therapy as Immunotherapy Outcomes Diminish in Glioblastoma
>> View Peer-Reviewed Articles
Most Popular
Key Takeaway Points in Phase III ALCYONE Trial for Multiple Myeloma
Finasteride Effective in Preventing Prostate Cancer
Enzalutamide Leads to Extended Radiographic PFS in Metastatic Hormone-Sensitive Prostate Cancer
Lenalidomide Maintenance Improves PFS, OS in Patients With Transplant-Eligible Multiple Myeloma
Publications
